IRVINE, Calif., Aug. 31, 2017 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, is scheduled to
present at the 11th Annual Wells Fargo Healthcare Conference at the
Westin Boston Waterfront in
Boston, Massachusetts on
Thursday, September 7, 2017.
Michael A. Mussallem, Edwards Lifesciences' chief
executive officer, is scheduled to speak to conference attendees at
8:10 a.m. PT (11:10 a.m. ET). A live webcast of the company
discussion will be available to all interested parties on the
Edwards Lifesciences investor relations website at
http://ir.edwards.com/events.cfm. Following the discussion,
an archived version of the webcast will be available on the Edwards
investor relations website in the News and Events section, and via
the Edwards Lifesciences Investor Relations App for mobile
devices.
About Edwards Lifesciences
Edwards Lifesciences, based in Irvine,
Calif., is the global leader in patient-focused medical
innovations for structural heart disease, as well as critical care
and surgical monitoring. Driven by a passion to help
patients, the company collaborates with the world's leading
clinicians and researchers to address unmet healthcare needs,
working to improve patient outcomes and enhance lives. For more
information, visit www.Edwards.com and follow us on Twitter at
@EdwardsLifeSci.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
View original content with
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-12th-annual-wells-fargo-healthcare-conference-300505678.html
SOURCE Edwards Lifesciences Corporation